Variables | Overall survival | Breast cancer related survival | ||
Hazard ratio (CI) | p-value | Hazard ratio (CI) | p-value | |
PR status (Ref: Yes) | 2.0 (1.3 - 2.9) | 0.0006 | 3.6 (2.3 - 5.6) | <0.0001 |
Stage (Ref: Stage 1) |
| <0.0001† |
| <0.0001† |
Stage 2 | 3.1 (1.6 - 6.1) | 0.0009 | 2.1 (0.9 - 4.5) | 0.0728 |
Stage 3 | 4.1 (1.9 - 9.2) | 0.0005 | 2.6 (1 - 6.7) | 0.0434 |
Stage 4 | 12.7 (5.4 - 29.8) | <0.0001 | 12.8 (4.9 - 33.5) | <0.0001 |
Chemotherapy (Ref: No) | 0.3 (0.2 - 0.4) | <0.0001 | 0.4 (0.3 - 0.6) | <0.0001 |
Hormonal therapy (Ref: No) | 0.7 (0.5 - 1) | 0.0419 |
|
|
Nottingham prognostic index (Ref: Poor) |
| 0.0002† |
| 0.0002† |
Good | 0.3 (0.1 - 0.6) | 0.0009 | 0.2 (0.1 - 0.6) | 0.0018 |
Moderate | 0.4 (0.3 - 0.7) | 0.0001 | 0.4 (0.2 - 0.6) | 0.0002 |